In the treatment of ALI/ARDS, glucocorticoids have been used for many years as they reduce inflammation and fibrosis through the inhibition of various cytokines, including IL-1, IL-3, IL-5, IL-6, IL-8, and TNF-α [20, 21]. This evidence concerns the gene CXCL8 and acute respiratory distress syndrome.